Elite Pharmaceuticals Inc (ELTP)

[The ELTP King]

It must be Generic Vyvanse then.

no2koolaid predicted this years ago which is why I put it in the iBox back then.

Comes off patent in JUST 2 days.

This is BY FAR Elite's biggest drug with an IQVIA of $2.53 BILLION, bigger than both the Adderalls.....COMBINED.

Elite will file the ANDA application within 2 months but no other competition except for Hikma can launch for 180 days anyways to try and get ahead start on us.

- "Takeda’s Vyvanse will lose its US exclusivity in August 2023 which will have significant knock-on effects for the company’s topline growth."

- "Hikma holds the first-time generic approval and will have 180 days of generic exclusivity from August 24, 2023."

Elite keeping the BE on the down low to keep the competition in the dark.